News
HLN
9.08
+0.33%
0.03
Haleon’s New Pain-Relief Study Offers Early Consumer Insight, but Limited Near-Term Stock Impact
TipRanks · 1d ago
Barclays Reaffirms Their Buy Rating on Haleon PLC (HLN)
TipRanks · 2d ago
Haleon Announces Purchase of 11 Million Shares Under Buyback Programme
TipRanks · 2d ago
Weekly Report: what happened at HLN last week (1109-1113)?
Weekly Report · 2d ago
Haleon PLC (HLN) Gets a Hold from RBC Capital
TipRanks · 6d ago
Haleon: If Staples Hold Up, The Stock Should Outperform
Seeking Alpha · 11/12 03:48
Buy 18 Ideal 'Safer' November Dividend Dogs Of 10-Year Tenured 81
Seeking Alpha · 11/11 23:27
Haleon Buys 12.6 Million Shares Under Buyback Programme
TipRanks · 11/09 11:47
Weekly Report: what happened at HLN last week (1102-1106)?
Weekly Report · 11/09 09:48
Haleon Held Amid Growth Misses and Margin Reset Risks as Price Target Is Cut to $320
TipRanks · 11/04 00:45
Haleon downgraded to Hold from Buy at Jefferies
TipRanks · 11/04 00:45
Haleon price target lowered to 390 GBp from 460 GBp at Morgan Stanley
TipRanks · 11/03 19:25
Goldman Sachs Sees Up to 250% Upside in These European Stocks, Adds Two New Picks
TipRanks · 11/03 12:08
Haleon Reports Director’s Purchase of 7,670 Shares
TipRanks · 11/02 14:34
Haleon Reports Total Voting Rights and Share Capital
TipRanks · 11/02 13:57
Haleon Purchases 4.49 Million Shares Under Buyback Programme
TipRanks · 11/02 11:57
Haleon downgraded to Hold from Buy at Berenberg
TipRanks · 11/02 10:05
Weekly Report: what happened at HLN last week (1026-1030)?
Weekly Report · 11/02 09:48
Haleon removed from European Conviction List at Goldman Sachs
TipRanks · 11/02 09:25
Bernstein Sticks to Its Hold Rating for Haleon PLC (HLN)
TipRanks · 11/02 09:16
More
Webull provides a variety of real-time HLN stock news. You can receive the latest news about Haleon through multiple platforms. This information may help you make smarter investment decisions.
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and others. The Company's segments include North America, Europe, Asia Pacific, and International. Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.